Veronique Rousseau-Orian

Karlsruhe, BW 76131, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 47 publications

Loss of CD44 re-educates pancreatic cancer-associated fibroblasts modulating their fibrotic and immunosuppressive functions.

Loss of CD44 re-educates pancreatic cancer-associated fibroblasts modulating their fibrotic and immunosuppressive functions.

Journal: Cell death & disease

Published: February 08, 2026

CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis.

CD44 in Group 1 Innate Lymphoid Cells Impacts the Development and Progression of Steatohepatitis.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: March 11, 2025

CD44 in myeloid cells is a major driver of liver inflammation and injury in alcohol-associated liver disease.

CD44 in myeloid cells is a major driver of liver inflammation and injury in alcohol-associated liver disease.

Journal: Hepatology (Baltimore, Md.)

Published: April 24, 2024

CD44: a stemness driver, regulator, and marker-all in one?

CD44: a stemness driver, regulator, and marker-all in one?

Journal: Stem cells (Dayton, Ohio)

Published: March 07, 2024

Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis.

Targeting CD44 and other pleiotropic co-receptors as a means for broad inhibition of tumor growth and metastasis.

Journal: Clinical & experimental metastasis

Published: November 20, 2023

High-throughput screening for cell binding and repulsion peptides on multifunctionalized surfaces.

High-throughput screening for cell binding and repulsion peptides on multifunctionalized surfaces.

Journal: Communications biology

Published: October 11, 2023

Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.

Identification of an Imidazopyridine-based Compound as an Oral Selective Estrogen Receptor Degrader for Breast Cancer Therapy.

Journal: Cancer research communications

Published: March 08, 2023

Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B.

Quantitative live imaging reveals a direct interaction between CD44v6 and MET in membrane domains upon activation with both MET ligands, HGF and internalin B.

Journal: Biochimica et biophysica acta. Biomembranes

Published: January 23, 2023

Different Involvement of Vimentin during Invasion by Listeria monocytogenes at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers In Vitro.

Different Involvement of Vimentin during Invasion by Listeria monocytogenes at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers In Vitro.

Journal: International journal of molecular sciences

Published: September 28, 2022

Automated high-throughput image processing as part of the screening platform for personalized oncology.

Automated high-throughput image processing as part of the screening platform for personalized oncology.

Journal: Scientific reports

Published: September 22, 2022

Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer.

Alternative splicing downstream of EMT enhances phenotypic plasticity and malignant behavior in colon cancer.

Journal: eLife

Published: July 19, 2022

CD44 expressed by myeloid cells promotes glioma invasion.

CD44 expressed by myeloid cells promotes glioma invasion.

Journal: Frontiers in oncology

Published: June 15, 2022

Showing 1-12 of 47

Last Updated: 09/26/2026